Among them, CD276 [60], ADORA2A [61], and NRP1 [62] have achieved remarkable success in tumor immunotherapy, which suggested USP28 expression was linked with infiltration levels, which indicates that the potential relationship between USP28 and the above immune regulatory genes may be worthy of further investigation. The gene discussed is CD276; the disease is neoplasm.